Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-cyclohexyl-5-butylbarbituric Acid
2. Paramidine
1. Paramidine
2. 841-73-6
3. Paramidin
4. Bucolom
5. 5-butyl-1-cyclohexylbarbituric Acid
6. Bucolomum
7. 5-butyl-1-cyclohexyl-2,4,6(1h,3h,5h)-pyrimidinetrione
8. Paramidin; Paramidine
9. 5-butyl-1-cyclohexyl-1,3-diazinane-2,4,6-trione
10. Barbituric Acid, 5-butyl-1-cyclohexyl-
11. 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-butyl-1-cyclohexyl-
12. Chebi:31314
13. 9t08ral174
14. Ncgc00181911-01
15. 5-butyl-1-cyclohexylpyrimidine-2,4,6(1h,3h,5h)-trione
16. Bucolome [inn:jan]
17. Bucolomo
18. Bucolomum [inn-latin]
19. Bucolomo [inn-spanish]
20. Einecs 212-666-1
21. Brn 0755320
22. Unii-9t08ral174
23. Paramidin (tn)
24. 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine
25. Bucolome (jan/inn)
26. Bucolome [inn]
27. Bucolome [jan]
28. Bucolome [mi]
29. Bucolome [mart.]
30. Bucolome [who-dd]
31. Dsstox_cid_28780
32. Dsstox_rid_83049
33. Dsstox_gsid_48854
34. Schembl25956
35. Chembl2106136
36. Dtxsid4048854
37. Tox21_113339
38. Hy-u00048
39. Cs-6752
40. Cas-841-73-6
41. 5-n-butyl-1-cyclohexylbarbituric Acid
42. D01661
43. Q4983624
| Molecular Weight | 266.34 g/mol |
|---|---|
| Molecular Formula | C14H22N2O3 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 266.16304257 g/mol |
| Monoisotopic Mass | 266.16304257 g/mol |
| Topological Polar Surface Area | 66.5 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 375 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Bucolome manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bucolome, including repackagers and relabelers. The FDA regulates Bucolome manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bucolome API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bucolome supplier is an individual or a company that provides Bucolome active pharmaceutical ingredient (API) or Bucolome finished formulations upon request. The Bucolome suppliers may include Bucolome API manufacturers, exporters, distributors and traders.
click here to find a list of Bucolome suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bucolome Drug Master File in Japan (Bucolome JDMF) empowers Bucolome API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bucolome JDMF during the approval evaluation for pharmaceutical products. At the time of Bucolome JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bucolome suppliers with JDMF on PharmaCompass.
Bucolome Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bucolome GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bucolome GMP manufacturer or Bucolome GMP API supplier for your needs.
A Bucolome CoA (Certificate of Analysis) is a formal document that attests to Bucolome's compliance with Bucolome specifications and serves as a tool for batch-level quality control.
Bucolome CoA mostly includes findings from lab analyses of a specific batch. For each Bucolome CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bucolome may be tested according to a variety of international standards, such as European Pharmacopoeia (Bucolome EP), Bucolome JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bucolome USP).
LOOKING FOR A SUPPLIER?
